Regenerative medicine through stem cell technology is a source of hope for many suffering from ailments including Alzheimer’s disease, diabetes, spinal cord injury and cancer. While new therapeutic options are continually in development, progress has, until recently, been hampered by political and medical ethics arguments. Because of patient advocacy, new technologies are now advancing, from development of an artificial pancreas to the hope of culturing intact human organs. In this interview with The Life Sciences Report, Bernie Siegel, founder and executive director of the Genetics Policy Institute, describes recent progress and developments in the regenerative medicine universe.
Recent Posts
- Treating spinal cord injuries with stem cells
- New CRISPR tool enables more seamless gene editing — and improved disease modeling
- Building a regenerative medicine industry: Lessons from North Carolina
- Healthspan Action Coalition and Kitalys Institute Propose Landmark Legislation to Promote Healthy Longevity
- Probing the Mysteries of the Aging Brain
- Cells That Build Themselves Into an Embryo? Scientists Just Made It Happen